Syndax Pharmaceuticals (SNDX) Amortizatization of Intangibles (2020 - 2026)

Syndax Pharmaceuticals' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $862000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 76.05% year-over-year to $862000.0; the TTM figure through Mar 2026 stood at $8.0 million (down 39.48% YoY), while the FY2025 annual figure was $10.8 million, down 20.16% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $862000.0, down from $1.5 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $4.0 million in Q1 2023, with the low at $53000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $3.1 million (2024), against an average of $2.5 million.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles jumped 7384.91% in 2023, then sank 76.05% in 2026.
• Syndax Pharmaceuticals' Amortizatization of Intangibles stood at $2.0 million in 2022, then jumped by 70.81% to $3.5 million in 2023, then slipped by 15.0% to $2.9 million in 2024, then slumped by 47.96% to $1.5 million in 2025, then plunged by 43.66% to $862000.0 in 2026.
• Business Quant data shows SNDX's Amortizatization of Intangibles at $862000.0 in Q1 2026, $1.5 million in Q4 2025, and $2.4 million in Q3 2025.